This study was performed after receiving permission from the institution’s human subjects committee as well as informed consent from the participants’ parents. In this randomized, double-blinded, controlled clinical trial, 90 children between the ages of 3 months and 7 years, ASA I–II, who were scheduled for elective unilateral inguinal herniorrhaphy were assigned to three equal groups (by using colored cards). Patients with a positive history of anticonvulsive, opioid, analgesic, sedative, corticosteroid, and nonsteroidal anti-inflammatory drug consumption were excluded from this study. For premedication, 0.02 mg/kg midazolam, 1 μg/kg fentanyl, and 0.02 mg/kg atropine were administered intravenously to all patients. The patients also received 5 mg/kg sodium thiopental and 0.5 mg/kg atracurium intravenously for induction of anesthesia and isoflurane (1%) with O2 and N2O (50%–50%) during the maintenance of anesthesia.
For postoperative analgesia, one group received suppository acetaminophen (20 mg/kg). Because of the average time of operation (30–45 minutes) and the delayed onset of the action of suppository acetaminophen (30–60 minutes), the acetaminophen was administered before premedication. In the second group, bupivacaine 0.5% (2 mg/kg) was infiltrated in the wound by the surgeon, and in the third group, a single-shot caudal block with bupivacaine 0.25% (0.75 mL/kg) was performed by the anesthesia provider at the end of surgery. Because the caudal blocks in children were performed while the child was anesthetized, it was not possible to assess the effectiveness of the block by testing for sensory analgesia levels. Thus, we predicted the success of caudal block from the laxity of the anal sphincter secondary to the reduction in sphincter tone from the local anesthetic block.
Initially, 30 minutes after operation in the recovery room and then every hour during the next 6 hours of postoperative period, the FLACC pain scale was applied by one trained researcher who was not aware of the methods of analgesia.
The FLACC pain scaling system is a behavioral pain assessment scale that is used to assess pain for children between the ages of 2–7 years or individuals that are unable to communicate their pain. The scale has five criteria, and each is assigned a score of 0, 1, or 2. The FLACC is scored in a range of 0–10, with 0 representing no pain, relaxed and comfortable; 1–3: mild discomfort; 4–6: moderate pain; 7–10: severe discomfort or pain or both (
10) (
Table 1).
During the study, if the FLACC pain score was 4 or over, 0.5 mg/kg of intravenous meperidine was administered postoperatively as a supplemental analgesic and recorded.
The data were transferred to the SPSS-10 software and analyzed statistically with chi-square and analysis of variance tests. P < 0.05 was considered significant.
The clinical trial registration number is: IRCT201110027695N1